Vir Biotechnology Inc.
(VIR)
undefined
undefined%
At close: undefined
7.57
1.47%
After-hours Dec 13, 2024, 07:12 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
Revenue | 86.18M | 1.58B | 1.09B | 67.25M | 711.00K | 868.00K | 149.00K |
Cost of Revenue | 2.77M | 146.32M | 65.86M | 301.58M | 148.47M | 100.23M | 62.51M |
Gross Profit | 83.42M | 1.43B | 1.02B | -234.33M | -147.76M | -99.36M | -62.36M |
Operating Income | -684.30M | 833.07M | 276.89M | -296.98M | -177.98M | -118.69M | -81.50M |
Interest Income | 86.99M | 28.09M | 439.00K | 2.84M | 8.51M | 2.54M | 638.00K |
Pretax Income | -628.19M | 754.28M | 549.80M | -298.61M | -174.53M | -116.36M | -80.78M |
Net Income | -615.06M | 515.84M | 528.58M | -298.67M | -174.68M | -115.88M | -69.85M |
Selling & General & Admin | 174.05M | 161.76M | 160.79M | 70.94M | 37.60M | 29.13M | 21.69M |
Research & Development | 589.67M | 474.65M | 448.01M | 302.41M | 148.47M | 100.23M | 62.51M |
Other Expenses | - | -35.33M | -8.35M | -9.12M | -7.38M | -212.00K | 83.00K |
Operating Expenses | 767.72M | 601.09M | 600.45M | 364.23M | 178.69M | 119.56M | 81.65M |
Interest Expense | - | 183.15M | - | - | - | - | - |
Selling & Marketing Expenses | - | - | - | - | - | - | - |
Cost & Expenses | 770.49M | 747.40M | 666.32M | 364.23M | 178.69M | 119.56M | 81.65M |
Income Tax | -13.08M | 238.44M | 21.22M | 54.00K | 154.00K | -480.00K | -10.92M |
Shares Outstanding (Basic) | 134.13M | 132.61M | 129.88M | 119.16M | 107.65M | 96.91M | 96.91M |
Shares Outstanding (Diluted) | 134.13M | 134.81M | 133.44M | 119.16M | 107.65M | 96.91M | 96.91M |
EPS (Basic) | -4.59 | 3.89 | 4.07 | -2.51 | -1.62 | -1.2 | -0.72 |
EPS (Diluted) | -4.59 | 3.83 | 3.96 | -2.51 | -1.62 | -1.2 | -0.72 |
EBITDA | -664.85M | 833.07M | 420.75M | -289.80M | -173.46M | -115.94M | -81.06M |
Depreciation & Amortization | 19.45M | 15.49M | 11.98M | 8.81M | 4.52M | 2.76M | 432.00K |